HS
AVXL icon

Horan Securities’s Anavex Life Sciences AVXL Stock Holding History

Horan Securities’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-200
Closed -$1.63K – 138
2023
Q2 		$1.63K Hold
200
– – ﹤0.01% 587
2023
Q1 		$1.71K Hold
200
– – ﹤0.01% 576
2022
Q4 		$1.85K Hold
200
– – ﹤0.01% 567
2022
Q3 		$2K Hold
200
– – ﹤0.01% 469
2022
Q2 		$2K Hold
200
– – ﹤0.01% 525
2022
Q1 		$2K Hold
200
– – ﹤0.01% 440
2021
Q4 		$3K Buy
+200
New +$3.8K ﹤0.01% 419
2021
Q2 		$5K Hold
200
– – ﹤0.01% 353
2021
Q1 		$3K Buy
+200
New +$2.18K ﹤0.01% 343

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Horan Securities's AVXL Position: Q3 2023 in Review

Horan Securities sold out of Anavex Life Sciences (AVXL) in Q3 2023, closing a stake of 200 shares — an estimated $1.63K sold.

Horan Securities first reported a position in AVXL in Q1 2021 and held it in 9 quarters. The position peaked at $5K in Q2 2021. 143 funds tracked by Wall St. Rank hold AVXL as of Q3 2023.

  • Horan Securities reported no remaining Anavex Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 200 Anavex Life Sciences shares in Q3 2023, an estimated $1.63K.
  • Horan Securities first reported a position in Anavex Life Sciences in Q1 2021 and held it in 9 quarters.
  • Horan Securities's Anavex Life Sciences position peaked at $5K in Q2 2021.
  • 143 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.